PAH: Treatment of Pulmonary Arterial Hypertension (PAH) | |
---|---|
13:30 – 13:50 | General measures R. Krishna Kumar, India |
13:50 – 14:10 | cGMP Treatment Tilman Humpl, Canda |
14:10 – 14:30 | Prostacyclin Treatment Shozaburo Doi, Japan |
14:30 – 14:50 | Endothelin Receptor Antagonist Treatment Maurice Beghetti, Switzerland |
14:50 – 15:10 | Interventional Approaches in Pulmonary Hypertension (BAS/Cath Potts) Dietmar Schranz, Germany |
15:10 – 15:30 | Surgical Approaches in PAH (Potts/Transplant) Damien Bonnet, France |